Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | DS-6157a |
Synonyms | |
Therapy Description |
DS-6157a is an antibody-drug conjugate (ADC) comprising an antibody that targets GPR20 linked to DXd, a DNA topoisomerase I inhibitor, which may inhibit tumor growth (PMID: 33579785). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
DS-6157a | DS 6157a|DS6157a | DS-6157a is an antibody-drug conjugate (ADC) comprising an antibody that targets GPR20 linked to DXd, a DNA topoisomerase I inhibitor, which may inhibit tumor growth (PMID: 33579785). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04276415 | Phase I | DS-6157a | DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST) | Terminated | USA | 1 |